Floxal (Floxal) eye drops analogs are cheaper. Price

Floxal is eye drops, which are produced by the German pharmaceutical company "Dr. Gerhard Mann ", g. Hamburg. This medication belongs to the pharmacotherapeutic group of broad-spectrum antibacterial agents.

Floxal is used in the treatment and prevention of ophthalmic diseases of infectious and inflammatory etiology. On the Russian market of pharmaceutical products, there is a wide selection of domestic and foreign drops, which are analogs of the drug Floxal.

Domestic and imported analogues

Floxal eye drops have the appearance of a clear solution with a yellowish tinge. This drug is an antimicrobial agent from the category of fluoroquinolones. Domestic and imported analogues of this medication have anti-inflammatory and antibacterial effects.

Tobrex

Tobrex is a Belgian ophthalmic drops produced by the pharmaceutical company Alcon-Couvreur.

This medication has the following pharmacological similarities with the drug Floxal:

• both drugs are broad-spectrum antibiotics;
• these medicines are used for the prevention and treatment of ophthalmic diseases, the occurrence of which is associated with infection of the organ of vision;
• the constituent components of Tobrex and Floxal eye drops show therapeutic efficacy against gram-positive and gram-negative microorganisms;
• drugs of these types act locally, without systemic absorption into the general bloodstream;
• ophthalmic drops Tobrex and Floxal have the same indications for use in patients who have received severe injuries of the eyeball, as well as have undergone surgical operations on the organ of vision (in this case, these medications are used in advance to prevent infection of damaged fabrics);
• both drugs destroy infectious microorganisms by damaging the structure of their cytoplasmic membranes;
• medicines Tobrex and Floxal relieve inflammation and swelling of the mucous membrane of the eyeball, accelerating the process of complete restoration of vision functions;
• these medicines can cause the same side effects in the form of itching, an increase in the volume of the conjunctiva, active lacrimation (similar symptoms indicate an individual intolerance to the active ingredients drops);
• ophthalmic solutions Tobrex and Floxal are not recommended for use by women who are pregnant or breastfeeding a newborn baby.

Medicines of these types have not only pharmacological similarities, but also a number of distinctive features.

They are as follows:

• the drug Tobrex is contraindicated for use in children under the age of 12 months, and the ophthalmic solution Floxal has no such restrictions;
• these medicines belong to one therapeutic category of antibacterial agents, but Tobrex belongs to the group of aminoglycosides, and Floxal belongs to fluoroquinolones;
• the active substance of Tobrex drops is the chemical compound tobramycin at a dosage of 3 mg per 1 ml of the finished solution, and the main component of Floxal is ofloxacin in a similar concentration;
• the dosage regimen of the drug Floxal provides for the introduction of this drug 1 drop from 2 to 4 times a day with a therapeutic course of no more than 14 days, and the procedure for using Tobrex medication is determined by an ophthalmologist on an individual basis, depending on the general condition of each the patient.

Eye drops Tobrex and Floxal have similar properties, but they are antibiotics of different pharmacological groups. The decision to interchange these medications should be made by an ophthalmologist, taking into account the strain of bacterial microflora that is found in the patient's eyes.

Ciprofloxacin

Floxal - eye drops (analogs of this drug are dispensed by prescription), which accelerate the healing process of the eyes.

This medication has the following pharmacological similarities with the ophthalmic agent Ciprofloxacin:

• both drugs are antimicrobial agents from the same group of fluoroquinolones;
• Ciprofloxacin and Floxal have an identical effect on the cellular structure of bacterial microorganisms, damaging their DNA;
• these medicines exhibit bactericidal properties against gram-negative microbes that are in a state of physiological rest, or they carry out cell division;
• ophthalmic solutions Ciprofloxacin and Floxal have the same destructive effect on gram-positive microorganisms, but only at the stage of their active division;
• drugs of these types have a higher antibacterial efficacy than similar eye drops from the group of aminoglycosides, tetracyclines, and also penicillins;
• both medicines do not cause addiction of infectious microorganisms to their active ingredients (after the use of Ciprofloxacin and Floxal on the mucous membrane of the eye practically does not remain persistent microbes);
• eye drops Ciprofloxacin and Floxal have the same level of binding to blood plasma proteins, which is in the range of 20-30%;
• drugs of these types have identical indications for use in the treatment of ulcerative lesions of the cornea and the anterior segment of the eye;
• ophthalmic solutions Ciprofloxacin and Floxal prevent the development of an infectious and inflammatory process in people who have undergone eye surgery, as well as undergo long-term rehabilitation after organ injuries vision;
• both medicines have a similar concentration of active substances, which is 3 mg per 1 ml of eye drops;
• these drugs are applied to the surface of the conjunctiva of the eye, but are not used for introduction into the anterior chamber of the organ of vision;
• ophthalmic solutions Ciprofloxacin and Floxal cause the same symptoms of an allergic reaction in people with individual sensitivity to antibiotics fluoroquinolones.

Floxal - eye drops (analogues of this medication are sold in most Russian pharmacies), which have the following differences from the drug Ciprofloxacin:

• these funds belong to a single pharmacological group of fluoroquinolone antibiotics, but at the same time medication Ciprofloxacin contains the active ingredient ciprofloxacin, and Floxal an antimicrobial component ofloxacin;
• the drug Ciprofloxacin can be used as the main therapeutic agent in the treatment of inflammatory processes in the tissues of the inner ear, and Floxal drops do not have such indications;
• ophthalmic solution Ciprofloxacin is prescribed for use in patients of newborn age, and there is no clinical data on the safety of the drug Floxal for the body of infants;
• the manufacturer of the drug Floxal has established a standard dosage regimen for this drug, and treatment with drops Ciprofloxacin is carried out according to special schemes, which are developed individually by an ophthalmologist, depending on the type eye diseases;
• Ciprofloxacin is produced by the Romanian pharmaceutical company Rompharm.

Floxal and Ciprofloxacin eye drops have minimal differences. In the therapeutic process, these medicines can be interchangeable. In the presence of identical pharmacological characteristics, the drug Ciprofloxacin is several times cheaper than its analogue Floxal.

Vitabact

Vitabakt is an imported analogue of the ophthalmic agent Floxal, which is produced by the French pharmaceutical company Excelvision.

These medicines have the following pharmacological similarities:

• both drugs are topical antimicrobial solutions that are used in the field of ophthalmology;
• drugs of these types have a low level of systemic absorption into the general bloodstream, which minimizes the risk of side effects;
• ophthalmic solutions Vitabact and Floxal are equally effective against bacterial infections that provoke inflammation and purulent processes in the eyeball;
• these drops are used for the course treatment of ophthalmic diseases, and are also used to prevent bacterial invasions;
• antiseptic solutions Vitabact and Floxal are equally indicated for patients who have previously undergone eye surgery;
• both drugs have an identical duration of a therapeutic course for a period of 10 days;
• in case of individual intolerance to the constituent substances of these medicines, patients have the same symptoms of a local allergic reaction in the form of redness of the mucous membrane of the eyes, conjunctival hyperemia, active lacrimation.

Floxal - eye drops (analogues of this drug have different costs), which have the following differences with the ophthalmic agent Vitabact:

• Vitabact is an antiseptic and an effective antimicrobial solution that is used in ophthalmology, but this medication does not belong to the category of antibiotics;
• the active substance of Vitabact eye drops is not ofloxacin, but the chemical compound picloxidine dihydrochloride at a concentration of 500 μg per 1 ml of the finished product;
• the drug Vitabakt is approved for use in relation to children of newborn age, and the antibacterial solution Floxal has no such indications.

The main distinguishing feature of Vitabact eye drops is that their active substance has a detrimental influence not only on bacterial microorganisms, but also destroys individual strains of viral and fungal infections.

Ofloxacin-Solopharm

Ofloxacin-Solopharm is an ophthalmic agent produced by the domestic pharmaceutical company Grotex.

This medication has the following similarities with Floxal solution:

• both drugs belong to the same pharmacological group of fluoroquinolone antibiotics;
• the medicines Ofloxacin-solofarm and Floxal have the same form of release in the form of a transparent yellowish solution without a specific odor;
• these medicines have a low level of absorption into the general bloodstream;
• the therapeutic effect of Ofloxacin-Solofarm and Floxal eye drops is to damage the DNA structure of pathogenic microorganisms, as well as the destruction of their cell membrane;
• both ophthalmic solutions are effective against Staphylococcus aureus, streptococcal infection, enterobacteria, chlamydia and mycoplasma;
• the drops of Ofloxacin-solofarm and Floxal contain a similar active ingredient ofloxacin at a concentration of 3 mg per 1 ml of the finished product;
• These drugs are used for complex treatment and preventive prevention of ophthalmic diseases in the form of blepharitis, keratitis, ulcerative lesions of the cornea of ​​the eye.

Medicines Ofloxacin-Solofarm and Floxal differ in the following characteristics:

• Ofloxacin-Solopharm is a domestically produced antiseptic;
• Ofloxacin-Solofarm is indicated for use as an antibacterial solution for the treatment of infectious and inflammatory diseases of the inner ear;
• eye drops Ofloxacin-solofarm are approved for use for the treatment of children over the age of 1 year, and the ophthalmological agent Floxal does not have such recommendations;
• the drug Ofloxacin-solopharm is contraindicated in women in a state of pregnancy and nursing mothers, and the manufacturer of the drug Floxal in conditions of urgent need allows the use of this funds.

Ophthalmic solutions Ofloxacin-solofarm and Floxal are analogous in chemical composition and therapeutic properties. If necessary, these drugs can be interchangeable.

Normax

Floxal - eye drops (analogues of the medication have an antimicrobial effect), which have the following pharmacological similarities with the ophthalmic agent Normax:

• preparations of these types have a similar release form in the form of a transparent antiseptic solution with yellowish tint, the therapeutic concentration of which is 3 mg of the main substance per 1 ml medication;
• eye drops Normax and Floxal belong to the same pharmaco-therapeutic group of broad-spectrum antibacterial agents from a number of fluoroquinolones;
• these medicines are prescribed for the systemic treatment of ophthalmic diseases, and are also used for the timely prevention of the pathological process in the organ of vision;
• antimicrobial solutions Normax and Floxal have similar pharmacodynamics in terms of harmful impact on bacterial infection, which is achieved by damaging the DNA structure of pathogenic microorganisms;
• both drugs are equally effective against most gram-positive and gram-negative microbes;

  

• eye drops Normax and Floxal destroy strains of Staphylococcus aureus, streptococcal infection, pathogens of chlamydia;
• ophthalmic solutions of these types have similar indications for use for the treatment of acute or a chronic form of conjunctivitis, blepharitis, keratitis, as well as ulcerative lesions of the cornea of ​​the eye;
• these medicines are applied to the surface of the conjunctival sac 1-2 drops up to 4 times a day;
• antibacterial agents Normax and Floxal have similar contraindications for their use in cases where a person has an individual sensitivity of the body to the constituents of the substance of ophthalmic solutions;
• both drugs are practically not absorbed into the general circulatory system, and also have a low level of binding to blood proteins (within 20-30%);
• after instillation of Normax and Floxal ophthalmic solutions, similar effects occur in the form of a burning sensation and cramps in the area of ​​the sore eye.

Normax is produced by the Indian pharmaceutical company Ipka Laboratories.

This medication has not only similarities with Floxal drops, but also these ophthalmic solutions are characterized by the following differences:

• the drug Normax can simultaneously be used to treat eye diseases and inflammatory pathologies of the inner ear, and Floxal has no such indications;
• the active ingredient of Normax ophthalmic solution is the chemical compound norfloxacin at a concentration of 3 mg;
• eye drops Normax are strictly prohibited for use in relation to patients under 18 years of age, and the drug Floxal does not have these restrictions (in case of therapeutic necessity, the ophthalmologist can independently select the dosage of this medication for the child corresponding age).

The active substances of the antibacterial solutions Normax and Floxal have insignificant differences. These medicines have similar properties, contain an active substance from one pharmacological group. These drugs are interchangeable.

Diclofenac

Ophthalmic agent Diclofenac in the form of drops has the following pharmacological similarities with the antibacterial solution Floxal:

• both medicines have anti-inflammatory effects;
• these drugs have the same form of release in the form of a clear solution with a yellowish tinge;
• eye drops Diclofenac and Floxal are introduced into the conjunctiva of the eye with further penetration of the medication into the anterior chamber of the organ of vision;
• these medicines can cause the same side effects in the form of burning sensation, itching, watery eyes, redness of the mucous membrane of the eye.

  

Ophthalmic solutions Diclofenac and Floxal have a common anti-inflammatory effect, but these medicines have more differences than pharmacological similarities.

They consist in the following characteristics:

• the drug Diclofenac belongs to a completely different therapeutic group of non-steroidal anti-inflammatory drugs;
• Diclofenac eye drops contain the active ingredient diclofenac sodium at a dosage of 1 mg per 1 ml of solution;
• the ophthalmic agent Diclofenac does not have an antibacterial effect, but only stops the inflammatory process and exhibits moderate analgesic properties;
• the use of Diclofenac drops can lead to a severe side effect in the form of clouding of the cornea of ​​the eye, and the Floxal solution does not cause such reactions in the body.

The drug Diclofenac can only be used to treat inflammatory eye diseases that are of a non-infectious origin. The main area of ​​application of this medication is to prepare patients for surgical interventions on the organ of vision, as well as relief of general symptoms during their postoperative rehabilitation.

Prices

The table below lists the main medicines that are analogues of the drug Floxal.

Name of the medication	Average prices in pharmacies
Tobrex	From 136 to 179 rubles. per bottle 5 ml
Ciprofloxacin	From 47 rubles. for a dropper bottle 5 ml
Vitabact	From 152 to 443 rubles. per bottle 10 ml
Ofloxacin-Solopharm	From 34 to 85 rubles. per bottle
Normax	From 100 to 193 rubles. per bottle 5 ml
Diclofenac	From 24 to 27 rubles. per bottle 5 ml

Floxal eye drops are an antibacterial agent that is used in ophthalmology. This medication shows therapeutic efficacy in the treatment of blepharitis, ulcerative lesions of the cornea of ​​the eye, conjunctivitis, keratitis. The drug Floxal is a broad-spectrum antibiotic, destroying especially dangerous bacterial strains in the form of Staphylococcus aureus and streptococcal infection.

The therapeutic effect of this drug is provided by the active ingredient ofloxacin. The average cost of the drug Floxal is 170 rubles. In the pharmacies of Russian cities, there is a large selection of domestic and foreign drops, which are analogues of this medication.

Video about the analogue of Floxal

Quickly about drugs. Diclofenac: